Where Can You Inject Ozempic? A Comprehensive Guide to Injection Sites

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections deliver medication subcutaneously once weekly, and choosing the right injection site directly affects how your body absorbs the medication and responds to treatment. Understanding approved injection locations, rotation patterns, and technique prevents lipohypertrophy (fatty tissue buildup) and ensures consistent therapeutic results. PlexusDx patients receive detailed injection training with their first shipment of compounded semaglutide.

Approved Semaglutide Injection Sites and Anatomy

Semaglutide injections are administered into the subcutaneous tissue layer beneath the skin, which lies between the dermis and muscle. Three primary injection areas meet clinical safety standards: the abdomen (at least 2 inches from the navel), the outer thigh (front or outer surface), and the upper arm (back of the arm between shoulder and elbow). Each site offers similar absorption rates when proper depth and angle are maintained, meaning you have flexibility in choosing comfortable locations based on your lifestyle and body composition.

The abdominal injection site represents the most commonly used location because it provides a large, accessible surface area and consistent subcutaneous depth for most body types. The outer thigh works well for patients who prefer injecting while sitting or for those with limited abdominal visibility. The upper arm injection site suits patients who want privacy or need someone to assist with their weekly injection. PlexusDx injection guides specify exact anatomical landmarks to help patients identify safe zones within each approved region.

Injection Site Rotation Schedule and Technique

Rotating between different injection sites prevents lipohypertrophy, a condition where repeated injections in the same spot cause fatty tissue to thicken and potentially reduce medication absorption. A weekly rotation pattern involves selecting a different site each week: abdomen one week, thigh the next, arm the third week, then returning to the abdomen. Within each injection site, patients should also rotate specific locations—for example, injecting the right abdomen one week and the left abdomen the next week. This systematic rotation distributes needle trauma across tissue and maintains consistent drug bioavailability throughout your treatment course.

Proper injection technique involves cleaning the skin with an alcohol swab, allowing it to air-dry completely, pinching the skin to create a raised fold, and inserting the needle at a 45 to 90-degree angle depending on body composition and needle length. After insertion, inject slowly over 3 to 5 seconds to allow the medication to distribute evenly through the subcutaneous space. Withdraw the needle and release the skin fold without applying excessive pressure to the injection site. Patients should avoid injecting directly over bruised areas, scars, or tender spots, and should allow at least one inch of distance between successive injection sites.

Signs of Injection Site Problems and Prevention

Lipohypertrophy develops gradually when injections repeatedly target the same area, creating raised, firm, or lumpy patches of thickened fatty tissue that may be painless but reduce medication absorption and effectiveness. Lipoatrophy (tissue loss) is less common with modern formulations but can occur if patients develop local immune reactions to the medication or repeated trauma. Both conditions are entirely preventable through consistent site rotation, proper injection depth, and attention to body landmarks. Patients who notice any persistent redness, warmth, swelling lasting more than 24 hours, or unusual firmness should report these changes to their PlexusDx healthcare provider.

Minor injection site reactions—including temporary redness, slight bruising, or mild discomfort—resolve within hours to days and do not require intervention. Applying ice for 10 minutes before injection can reduce bruising risk, particularly in patients with sensitive skin or thin tissue. Using a fresh needle for each injection, ensuring the medication reaches room temperature before injection, and avoiding vigorous rubbing of the injection site all contribute to minimizing local reactions. PlexusDx compounded semaglutide is formulated at pharmaceutical-grade purity, which reduces the risk of site reactions compared to some lower-quality preparations.

Personalized Injection Planning Through Precision Peptide Genetic Testing

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with certain genetic profiles may experience faster medication absorption or more pronounced appetite suppression, which informs decisions about injection site selection, timing relative to meals, and dose progression schedules. While all patients rotate injection sites to prevent lipohypertrophy, those with genetic variations affecting subcutaneous absorption benefit most from consistency in anatomical location timing—for example, always injecting the abdomen on Friday evenings. PlexusDx pharmacists integrate genetic test results with injection site guidance to create individualized protocols that maximize medication effectiveness and minimize unnecessary side effects.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week, or do I have to rotate?

Rotating injection sites weekly is essential to prevent lipohypertrophy and maintain consistent medication absorption. Injecting the same spot repeatedly causes fatty tissue to thicken, which can reduce how effectively your body absorbs semaglutide. PlexusDx recommends a three-site rotation pattern: abdomen, thigh, and upper arm, cycling through each location on a weekly basis.

What depth should semaglutide be injected, and how do I know if I'm injecting correctly?

Semaglutide is injected into the subcutaneous layer at a 45 to 90-degree angle depending on your body composition, approximately one-half inch beneath the skin surface. Your PlexusDx injection training guide includes diagrams showing proper needle angle and depth. If you experience sharp pain, bleeding, or medication leaking back out, you may be injecting too shallow; if you feel pressure that seems unusually deep, you may be inserting past the subcutaneous layer.

How much does compounded semaglutide cost at PlexusDx, and are there payment options?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across three commitment tiers, with no flat per-compound pricing increases—your dose may go up, but your price won't. PlexusDx serves all 50 states without requiring insurance, and HSA and FSA accounts are eligible for payment. No membership fees apply.

What should I do if I develop a bruise, lump, or redness at an injection site?

Minor redness or bruising typically resolves within 24 hours and requires no treatment. However, persistent lumps, warmth lasting more than 24 hours, or signs of infection (increasing redness, drainage, fever) warrant contact with your PlexusDx healthcare provider. Applying ice before injection and ensuring proper site rotation prevent most injection site complications.

Can the PlexusDx Precision Peptide Genetic Test help me with injection site planning?

Yes. Genetic variants like GLP1R rs6923761 influence your subcutaneous absorption rate and medication response profile, which informs optimal injection timing and site consistency strategies. After your first month of semaglutide therapy, the $298 Precision Peptide Genetic Test maps 14 pathways across 49 peptides, providing personalized insights that help PlexusDx clinicians tailor your injection protocol for maximum effectiveness.

Related Reading

• Injection Sites For Ozempic
• Ozempic Injection Sites
• Injection Ozempic
• Mounjaro Injection Sites

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.